Prenetics Global Limited

NasdaqGM PRE

Prenetics Global Limited Capital Expenditure for the year ending December 31, 2023: USD -911.81 K

Prenetics Global Limited Capital Expenditure is USD -911.81 K for the year ending December 31, 2023, a 85.62% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Prenetics Global Limited Capital Expenditure for the year ending December 31, 2022 was USD -6.34 M, a 44.42% change year over year.
Prenetics Global Limited Capital Expenditure for the year ending December 31, 2021 was USD -11.41 M, a -272.94% change year over year.
Prenetics Global Limited Capital Expenditure for the year ending December 31, 2020 was USD -3.06 M, a -718.51% change year over year.
Prenetics Global Limited Capital Expenditure for the year ending December 31, 2019 was USD -373.86 K.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

NasdaqGM: PRE

Prenetics Global Limited

CEO	Mr. Sheng Wu Yeung
IPO Date	July 16, 2021
Location	Hong Kong
Headquarters	Unit 701-706, K11 Atelier King’s Road
Employees	320
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Clinical Trials Drugstores & Retail Pharmacies Eyewear Medical Instruments Personal Care Pharmaceuticals

Description

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Key trends

Past 5 years